BioGenerator 20 South Sarah Street St. Louis, MO 63108 314-615-6355 info@biogenerator.org Investor Login Menu Search for: Home About About Mission History Team Partners Governance Resources Portfolio Our Approach Our Approach Investing Advising Infrastructure News Contact Who Is BioGenerator? BioGenerator is an evergreen investor that creates, grows, and invests in promising companies and entrepreneurs in the St. Louis region. BioGenerator identifies and de-risks commercially promising innovations and services; advises innovators and entrepreneurs; recruits and supports entrepreneurial talent; makes staged investments grounded in rigorous due diligence; and offers access to lab space and capital equipment. We position companies to navigate the unique challenges of early-stage bioscience company development. BioGenerator is the investment arm of BioSTL Adarza is a next-generation multiplex immunoassay product company focused on applications in life science tools and the in vitro diagnostics markets. Adarzas products and services utilize its proprietary Arrayed Imaging Reflectometry (AIR) detection platform that is capable of rapid identification and quantification and offers key performance benefits in multiplexing, sensitivity, speed, sample size, dynamic range, and ease of use while affording industry-leading low cost. The AIR platform addresses many commercial applications, including disease biomarkers, personalized medicine, drug and vaccine development, allergy, immunology, and infectious diseases research. Our Companies The BioGenerator portfolio is a compilation of companies within the health and plant sciences including therapeutics, diagnostics, medical devices, research tools, agriculture and IT. Our Companies The BioGenerator portfolio includes companies within the health and plant sciences including therapeutics, diagnostics, medical devices, research tools, agriculture and IT. View Full Portfolio News MediBeacon Inc. Acquires Mannheim Pharma Diagnostics06/14/2016 Read More 2015 BioGenerator Annual Report Release05/19/2016 Read More BioGenerator Invests in Innovative Health IT Company, MedAware Solutions03/22/2016 Read More BioGenerator Invests in New Immunotherapy Company, Unleash02/18/2016 Read More BioGenerator Portfolio Company Galera Therapeutics Raises $42 Million Series B02/05/2016 Read More BioGenerator Leads Investment in Accuronix Therapeutics01/27/2016 Read More BioGenerator Invests in $800,000 Round for Ag Biotech Company, Edison Agrosciences01/25/2016 Read More BioGenerator Invests in $1.2 Million Round for Ag Tech Company, S412/17/2015 Read More See All News What Others Are Saying "The St. Louis startup community is flourishing. Weve discovered and invested in several of our most promising companies there. I continue to be impressed by the BioGenerator model and the quality of their portfolio." Dan Watkins Managing Director, Mercury Fund Stay Updated Stay up to date with the latest BioGenerator news and details. Enter Your Email Address* First Name* Last Name* Company Name* About BioGenerator Mission History Team Partners Governance Our Approach Investing Advising Infrastructure More Home Portfolio News Contact BioGenerator 20 South Sarah Street St. Louis, MO 63108info@biogenerator.org © 2015 BioGenerator | All Rights Reserved